4.9.5.2Vertical

Clinical Reference Labs

National and regional labs processing outpatient diagnostic testing.

Market snapshot

These figures describe Laboratory & Diagnostic Services (4.9.5), the segment that Clinical Reference Labs sits within. They are not figures for Clinical Reference Labs on its own.

Market size
~$76B
Growth
~10.1%CAGR (2017–22, nominal)
Companies
~4,829 firms
Firms by employee count

75.3% of firms have fewer than 20 employees: 3,638 micro-businesses, below most mandates.

The investable universe1,191 firms with 20+ employees
20–99
63453%
100–499
30926%
500+
24821%

~4,800 medical-lab and blood/organ-bank firms; the ~10%/yr growth and ~$76B are inflated by the 2022 COVID-testing surge and will normalize lower. It is a scaling, consolidating services layer (Labcorp and Quest at the top) with a long fragmented tail of specialty and reference labs: a deep strategic-buyer pool.

NAICS 621511, 621991. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

Business model & economics

Revenue model

Per-test reimbursement across clinical and specialty testing

Key economics

Revenue per firm
$15,732,062
Revenue per employee
$224,750
Employees per firm
67.5
Recurring revenue
Moderate–High

recurring testing volume

EBITDA margin
15–25%
Capex intensity
High

Characteristics

  • Balanced cost base: payroll is 29% of revenue, leaving room to scale margin without cutting staff
  • Deep strategic-buyer pool: 248 firms exceed 500 employees, so a scaled asset has trade buyers
  • Reference-lab market consolidated around Labcorp and Quest.
  • COVID-testing surge inflated 2020–22, then normalized.
  • Molecular and genetic testing the durable growth driver.

NAICS 621511, 621991. U.S. Census Bureau, 2022 Statistics of U.S. Businesses; U.S. Census Bureau, 2022 Economic Census.

M&A deal context

Deal activityHigh

Who’s acquiring

  • Reference-lab majors
  • Genomic & specialty-testing acquirers
  • PE-backed lab consolidators

What’s driving deals

  • Acquisition of hospital outreach and specialty labs.
  • Molecular and precision-diagnostics growth.
  • Consolidation around scaled reference labs.

Find Clinical Reference Labs acquisition targets

Search Acquisera’s index for companies classified under Clinical Reference Labs (4.9.5.2) and build a targeted deal pipeline.

Search companies